(BUSINESS WIRE)--Life Technologies Corporation (NASDAQ: LIFE) today announced a series of new product innovations across the company’s DNA sequencing portfolio. To date, most sequencing technologies have primarily addressed the needs of researchers in the highest throughput laboratories, limiting widespread accessibility of these powerful next-generation sequencing technologies. As a pioneer of DNA sequencing, Life Technologies continues to enable researchers in any size laboratory to access applications that meet their specific technical and financial research requirements. As a result of these innovations, researchers now have greater flexibility from their sequencing platforms, a more simplified sample preparation, increased data throughput and expedited data analysis.
